Literature DB >> 14500526

Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Guérin vaccination.

Masayuki Umemura1, Hitoshi Nishimura, Kimika Saito, Toshiki Yajima, Goro Matsuzaki, Satoru Mizuno, Isamu Sugawara, Yasunobu Yoshikai.   

Abstract

Interleukin-15 (IL-15) transgenic mice which had been inoculated with Mycobacterium bovis bacillus Calmette-Guérin (BCG) 24 weeks previously showed resistance against airborne infection with Mycobacterium tuberculosis H37Rv accompanied by an increased CD8(+)-Tc1-cell response. IL-15 may be used as an immune adjuvant given with BCG vaccination to enhance its biologic efficacy.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14500526      PMCID： PMC201060          DOI： 10.1128/IAI.71.10.6045-6048.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  16 in total

1.  Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guérin infection via augmentation of NK and T cytotoxic 1 responses.

Authors:  M Umemura; H Nishimura; K Hirose; T Matsuguchi; Y Yoshikai
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

Authors:  J D Pfeifer; M J Wick; R L Roberts; K Findlay; S J Normark; C V Harding
Journal:  Nature       Date:  1993-01-28       Impact factor: 49.962

Review 3.  The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens.

Authors:  T A Waldmann; Y Tagaya
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

4.  Relative importance of NF-kappaB p50 in mycobacterial infection.

Authors:  H Yamada; S Mizuno; M Reza-Gholizadeh; I Sugawara
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 5.  BCG vaccination against tuberculosis: past disappointments and future hopes.

Authors:  P W Roche; J A Triccas; N Winter
Journal:  Trends Microbiol       Date:  1995-10       Impact factor: 17.079

6.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.

Authors:  J P Lodolce; D L Boone; S Chai; R E Swain; T Dassopoulos; S Trettin; A Ma
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

7.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice.

Authors:  Yu-Jin Jung; Ronald LaCourse; Lynn Ryan; Robert J North
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

9.  Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis.

Authors:  S M Behar; C C Dascher; M J Grusby; C R Wang; M B Brenner
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

10.  Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells.

Authors:  A A Izzo; R J North
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307
View more
  7 in total

1.  Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen.

Authors:  Wei Zhang; Sheng-Fu Dong; Shu-Hui Sun; Yuan Wang; Guang-Di Li; Di Qu
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

2.  Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.

Authors:  Avi-Hai Hovav; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Yogesh A Bangale; Marian L Kruzel; Jeffrey K Actor
Journal:  Med Microbiol Immunol       Date:  2007-03-22       Impact factor: 3.402

4.  Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.

Authors:  Elizabeth Bolesta; Aleksandra Kowalczyk; Andrzej Wierzbicki; Cheryl Eppolito; Yutaro Kaneko; Masafumi Takiguchi; Leonidas Stamatatos; Protul A Shrikant; Danuta Kozbor
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice.

Authors:  Vanja Lazarevic; David J Yankura; Sherrie J DiVito; JoAnne L Flynn
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers.

Authors:  Kamal U Saikh; Teri L Kissner; Steven Nystrom; Gordon Ruthel; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2007-11-28

7.  Human cord blood γδ T cells expressing public Vγ2 chains dominate the response to bisphosphonate plus interleukin-15.

Authors:  Cristiana Cairo; Bertrand Sagnia; Giulia Cappelli; Vittorio Colizzi; Rose G F Leke; Robert J Leke; C David Pauza
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.